Hostname: page-component-7c8c6479df-p566r Total loading time: 0 Render date: 2024-03-28T14:13:35.535Z Has data issue: false hasContentIssue false

Protein-Based Hydrogels for Cell Transplantation under Constant Physiological Conditions

Published online by Cambridge University Press:  01 February 2011

Cheryl T Wong Po Foo
Affiliation:
cherylwongpofoo@stanford.edu, Stanford University, Materials Science and Engineering, 476 Lomita Mall, McCullough Building, Room 246, Stanford, CA, 94305-4045, United States
Sarah Heilshorn
Affiliation:
heilshorn@stanford.edu, Stanford University, Materials Science and Engineering, 476 Lomita Mall, McCullough Building, Room 246, Stanford, CA, 94305-4045, United States
Get access

Abstract

A promising treatment for multiple neurological disorders including stroke, Huntington's, and Parkinson's is the transplantation of stem cells into the diseased site to promote regeneration of the neural tissue. However, viability of transplanted cells is often low (15-35%) and unpredictable. Cell viability has been directly correlated with functional outcome of the treatment, motivating the development of more reliable cell transplantation procedures. To protect transplanted cells from shear stress during injection and from the hostile, inflammatory environment of the diseased brain tissue, many research groups are exploring physical hydrogels as a protective, growth-permissive matrix to enhance cell viability. However, physical hydrogels require an environmental trigger to induce gelation. These environmental triggers include sudden changes in temperature, pH, or salt concentration - all of which are detrimental to encapsulated cells and proteins and complicate their use in a clinical environment. To address this need, we have designed a two-component, protein-based hydrogel system that can self-assemble under constant physiological conditions.

Both components of the hydrogel system are created using recombinant protein technology, which allows synthesis of exact monomer sequences within monodisperse polymers. The first hydrogel component is a block copolymer made of several repeats of a peptide sequence encoding the WW domain-fold, a short triple-stranded, anti-parallel, beta-sheet. The WW domains are interspersed with a random-coil, hydrophilic spacer to enhance polymer flexibility and solubility. The second hydrogel component is made of several repeats of a polyproline rich peptide sequence interspersed with a random-coil, hydrophilic spacer. Upon mixing the two hydrogel components together, the WW-domains in component 1 and the polyproline rich peptides in component 2 bind together with 1:1 stoichiometry. This binding has an apparent association constant of 2.2×105 M, as measured by isothermal titration calorimetry. This peptide-binding event serves as the physical crosslinks to form a polymeric network composed of the two components. Because gelation is initiated by simply mixing the two components together at physiological pH, temperature, and ionic strength, this system is highly biocompatible and easy to use. Furthermore, the precision of protein engineering allows both components to be easily modified. For example, increasing the length of the hydrophilic spacers will increase the resulting network pore size. Additionally, bioactive peptide sequences, such as the RGD cell-binding domain, have been introduced into the hydrophilic spacers to modify cell-scaffold interactions. Our long-term objective is to design a self-assembling hydrogel system for cell delivery that will both improve cell viability and mimic many of the essential cues in the developmental niche to encourage cell differentiation and outgrowth.

Type
Research Article
Copyright
Copyright © Materials Research Society 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

[1] Bliss, T. M, Kelly, S., Shah, A. K, Foo, W. C, Kohli, P., Stokes, C., Sun, G. H, Ma, M., Masel, J., Kleppner, S. R, Schallert, T., Palmer, T., and Steinberg, G. K, “Transplantation of hNT neurons into the ischemic cortex: cell survival and effect on sensorimotor behavior,” J Neurosci Res, vol. 83, pp. 1004–14, 2006.Google Scholar
[2] Kelly, S., Bliss, T. M, Shah, A. K, Sun, G. H, Ma, M., Foo, W. C, Masel, J., Yenari, M. A, Weissman, I. L, Uchida, N., Palmer, T., and Steinberg, G. K, “Transplanted human fetal neural stem cells survive, migrate, and differentiate in ischemic rat cerebral cortex,” Proc Natl Acad Sci U S A, vol. 101, pp. 11839–44, 2004.Google Scholar
[3] Saporta, S., Borlongan, C. V, and Sanberg, P. R, “Neural transplantation of human neuroteratocarcinoma (hNT) neurons into ischemic rats. A quantitative dose-response analysis of cell survival and behavioral recovery,” Neuroscience, vol. 91, pp. 519–25, 1999.Google Scholar
[4] Kordower, J. H, Freeman, T. B, Chen, E. Y, Mufson, E. J, Sanberg, P. R, Hauser, R. A, Snow, B., and Olanow, C. W, “Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease,” Mov Disord, vol. 13, pp. 383–93, 1998.Google Scholar
[5] Kordower, J. H, Freeman, T. B, Snow, B. J, Vingerhoets, F. J, Mufson, E. J, Sanberg, P. R, Hauser, R. A, Smith, D. A, Nauert, G. M, Perl, D. P, and et al. , “Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease,” N Engl J Med, vol. 332, pp. 1118–24, 1995.Google Scholar
[6] Mahoney, M. J and Anseth, K. S, “Three-dimensional growth and function of neural tissue in degradable polyethylene glycol hydrogels,” Biomaterials, vol. 27, pp. 2265–74, 2006.Google Scholar
[7] Schense, J. C, Bloch, J., Aebischer, P., and Hubbell, J. A, “Enzymatic incorporation of bioactive peptides into fibrin matrices enhances neurite extension,” Nat Biotechnol, vol. 18, pp. 415–9, 2000.Google Scholar
[8] Silva, G. A, Czeisler, C., Niece, K. L, Beniash, E., Harrington, D. A, Kessler, J. A, and Stupp, S. I, “Selective differentiation of neural progenitor cells by high-epitope density nanofibers,” Science, vol. 303, pp. 1352–5, 2004.Google Scholar
[9] Petka, W. A, Harden, J. L, McGrath, K. P, Wirtz, D., and Tirrell, D. A, “Reversible hydrogels from self-assembling artificial proteins,” Science, vol. 281, pp. 389–92, 1998.Google Scholar
[10] Shen, W., Lammertink, R.G.H., Sakata, J.K., Kornfield, J.A., Tirrell, D.A., “Assembly of an artificial protein hydrogel through leucine zipper aggregation and disulfide bond formation,” Macromolecules, vol. 38, pp. 39093916, 2005.Google Scholar
[11] Russ, W. P, Lowery, D. M, Mishra, P., Yaffe, M. B, and Ranganathan, R., “Natural-like function in artificial WW domains,” Nature, vol. 437, pp. 579–83, 2005.Google Scholar
[12] Mcgrath, K. P, Fournier, M. J, Mason, T. L, and Tirrell, D. a, “Genetically Directed Syntheses of New Polymeric Materials - Expression of Artificial Genes Encoding Proteins with Repeating (Alagly)3Proglugly Elements,” Journal of the American Chemical Society, vol. 114, pp. 727733, 1992.Google Scholar
[13] Koepf, E. K, Petrassi, H. M, Ratnaswamy, G., Huff, M. E, Sudol, M., and Kelly, J. W, “Characterization of the structure and function of W -> FWW domain variants: Identification of a natively unfolded protein that folds upon ligand binding,” Biochemistry, vol. 38, pp. 1433814351, 1999.+FWW+domain+variants:+Identification+of+a+natively+unfolded+protein+that+folds+upon+ligand+binding,”+Biochemistry,+vol.+38,+pp.+14338–14351,+1999.>Google Scholar